Sanguine Solutions Systems India Profile
Key Indicators
- Authorised Capital ₹ 4.90 M
as on 06-12-2024
- Paid Up Capital ₹ 1.10 M
as on 06-12-2024
- Company Age 8 Year, 2 Months
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 2.00 Cr
as on 06-12-2024
- Revenue 805.33%
(FY 2019)
- Profit -3009.80%
(FY 2019)
- Ebitda -123.02%
(FY 2019)
- Net Worth -442.91%
(FY 2019)
- Total Assets 11.36%
(FY 2019)
About Sanguine Solutions Systems India
The Company is engaged in the Engineering Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 4.90 M and a paid-up capital of Rs 1.10 M.
The company currently has active open charges totaling ₹2.00 Cr.
Taufiq Shaikh, Chandrakant Mate, Neelam Chaurasia, and One other member serve as directors at the Company.
- CIN/LLPIN
U31101PN2016PTC166646
- Company No.
166646
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Oct 2016
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Sanguine Solutions Systems India?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Akash Joshi  | Director | 02-Sep-2017 | Current |
| Taufiq Shaikh | Director | 03-Sep-2018 | Current |
| Chandrakant Mate | Director | 18-Aug-2017 | Current |
| Neelam Chaurasia | Director | 03-Oct-2016 | Current |
Financial Performance of Sanguine Solutions Systems India.
Sanguine Solutions Systems India Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 805.33% increase. The company also saw a substantial fall in profitability, with a 3009.8% decrease in profit. The company's net worth observed a substantial decline by a decrease of 442.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sanguine Solutions Systems India?
In 2019, Sanguine Solutions Systems India had a promoter holding of 9.09% and a public holding of 90.91%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Dena Bank Creation Date: 04 Sep 2017 | ₹2.00 Cr | Open |
How Many Employees Work at Sanguine Solutions Systems India?
Unlock and access historical data on people associated with Sanguine Solutions Systems India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanguine Solutions Systems India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanguine Solutions Systems India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
